The $CRWD disaster had me looking for stocks in Geoinvesting’s microcap coverage universe that might have competitive offerings or offerings that could work with Crowdstrike to prevent future similar disasters. That’s when I realized that we had already written a short Reasons for Tracking (RFT) on $CSPI on September 28, 2023. stock is actually up 73% since we published the RFT. At the time we published the RFT, we noticed that the company had launched a proprietary cybersecurity software platform to help jumpstart growth and complement its unexciting, yet profitable, legacy business offering third-party hardware and software IT solutions.
GLP-1 is the hottest NEW weight loss treatment and was brought to market by Eli Lilly and Company (NYSE:LLY) in January of this year, propelling its stock to rise 35% this year.
The company we are talking about has over $100 million in trailing 12 month revenues, and the CEO is insinuating that its upcoming new weight loss GLP-1 product launch “will be a “game changer.”
Let’s start out this week’s stock commentary with AWW, a “turnaround company” in our Run to $1 Model Portfolio that manufactures and markets health and beauty aids. GeoInvesting’s “Run to $1.00 Model Portfolio” (R21) focuses on microcap stocks trading under $1 per share that have the potential to exceed this threshold.
The newest product from CCA Industries is Neutein, a brain health supplement. Launched in the second quarter of fiscal 2024, Neutein is now available in 3,420 CVS stores across the country. This product is part of the company’s efforts to turn around their financial performance and is supported by a marketing campaign featuring NFL Hall of Fame football player Mike Singletary.
It’s refreshing to see the microcaps rebound after a somewhat tepid last two months, during which many stocks we track were down significantly from their highs. On this point, in our June 2024 Review monthly newsletter, you might have noticed that we adjusted our Model Portfolio/Screen performance table to reflect stocks rising only more than 10%. We did this to be able to actually include about the same amount of stocks we are usually able to highlight when using our usual 20% to 25% benchmark.
So, this rally in the smaller cap market, spurred by the recently reported cool inflation numbers, marks the first major movement since the end of 2023, when it rose nearly 30% in the last 2 months of 2023.
Earlier this month, I was pleased to see our team worked hard to ensure that our July 2024 Monthly Open Forum kicked off right at the start of July. We’re committed to maintaining this schedule for future Monthly Forums, focused on bringing you the previous month’s highlights early, before rolling too deep into the next each month. This timing helps our team focus on delivering more value-added research throughout the month rather than preparing for the forum.
This past week, I was pleased to see our team worked hard to ensure that our July 2024 Monthly Open Forum kicked off right at the start of July. We’re committed to maintaining this schedule for future Monthly Forums, focused on bringing you the previous month’s highlights early, before rolling too deep into the next each month. This timing helps our team focus on delivering more value-added research throughout the month rather than preparing for the forum.